atezolizumab,bevacizumab
roche
['atezo', 'bevacizumab', 'tecentriq', 'imbrave050', 'genentech']
imbrave050 trial shows atezolizumab plus bevacizumab may be "a practice-changing adjuvant treatment option" for patients with high-risk hepatocellular carcinoma. #asco23 #livercancer #tecentriq 
The content you need, when you need it.